BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 31, 2021
View Archived Issues
CARB-X grant supports development of SNIPR-001 to prevent E. coli infections in cancer patients
Read More
First-in-human PET imaging study and radiation dosimetry of thiamine derivative [11C]TTFD
Read More
Eph/ephrin inhibitor UniPR-1331 counters inflammation in Crohn's disease model
Read More
TUBB4B inhibition could treat nonalcoholic fatty liver disease-associated hepatocellular carcinoma
Read More
Phase I/II study of RVU-120 in solid tumors approved in Poland
Read More
Gene therapy can address infantile Parkinson's
Read More
Guangzhou Henovcom Bioscience patents ENPP2 inhibitors
Read More
Northwest Agriculture & Forestry University divulges new DprE1 inhibitors
Read More
Chinese investigators disclose new componds for schizophrenia
Read More
Nanjing Sanhome Pharmaceutical synthesizes PTPN11 inhibitors
Read More
Affibody describes new compounds for HMGB1-related disorders
Read More
Ziltivekimab reduces biomarkers of inflammation and thrombosis in phase II RESCUE study
Read More
Phase I trial investigates MT-6402 in PD-L1-expressing advanced solid cancer
Read More
NIDA studies TRV-734 in phase II for opioid use disorder
Read More
BPRCX-807 demonstrates promising activity in models of HCC
Read More
Enrollment opens in phase IIb study of ARO-APOC3 in severe hypertriglyceridemia
Read More
Phase I trial explores use of BIVV-001 in adults with type 2N and 3 von Willebrand disease
Read More
RNF6 and SF3B2 are novel therapeutic targets in colorectal cancer
Read More
Disulfiram/copper gluconate studied in phase I for treatment-refractory multiple myeloma
Read More
Liminal stops plans to advance fezagepras into trials for IPF and hypertriglyceridemia
Read More
SCOHIA advances somatostatin SST5 receptor antagonist SCO-240 into phase I study
Read More
Prefusion F-based nanovaccine confers durable protection against RSV infection in mice
Read More
Extracellular nicotinamide phosphoribosyltransferase suggested as a viable ARDS therapeutic target
Read More
SRSF2 is an oncogenic factor in PDAC and PC
Read More